KELSEY HAMILL: Open Payments
NPI 1831725407 · THORNDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,617 in 51 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $99 · 2025 $1,617
Food & beverage: $1,532Education: $85
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 5 | $426 |
| ABBVIE INC. | 11 | $255 |
| Janssen Biotech, Inc. | 9 | $253 |
| GENZYME CORPORATION | 4 | $177 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $99 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $97 |
| Aimmune Therapeutics, Inc. | 2 | $73 |
| Ardelyx, Inc. | 3 | $59 |
| Ipsen Biopharmaceuticals, Inc | 2 | $48 |
| Celltrion USA Inc. | 1 | $34 |
Products named: REZDIFFRA, TREMFYA, RINVOQ, DUPIXENT, XIFAXAN, ENTYVIO, ZENPEP, IBSRELA.
Industry payments across PA — which companies pay providers there.
